Biocorrx Inc. Announces Expansion Of The Start Fresh Program To Include Treatment Of Opioid Dependence
3/4/2014 9:04:20 AM
Los Angeles, March 4, 2014 (GLOBE NEWSWIRE) -- BioCorRx Inc. ('the Company") (OTCQB: BICX) is pleased to announce the expansion of their revolutionary Start Fresh Program. In light of an escalating problem to society, as well as patient demand the Company is opening up the program to treat opioid addiction. The abuse of prescription painkillers burdens the U.S. healthcare system with an estimated annual cost of $72 billion, and according to the Centers for Disease Control prescription drug overdose deaths have more than quadrupled since 1999. While actual statistics on drug abuse are difficult to compile, CDC estimates that for every one death there are 825 non-medical users of prescription painkillers. "Expanding our cutting-edge treatment program to help individuals addicted to painkillers is a natural next step for us and we feel confident about grasping a piece of the estimated $1 billion in annual revenue generated by this market" said Kent Emry, CEO of BioCorRx.
Help employers find you! Check out all the jobs and post your resume.
comments powered by